Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration-Reference-Cited by-同舟云学术

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

Published:2020-08-20 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zhao Shujuan,Hong Xuejiao,Cao Jingjing,Cai Haixia,Du Song,Ma Peizhi

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference47 articles.

1. Anticoagulant options–why the FDA approved a higher but not a lower dose of dabigatran;Beasley;N. Engl. J. Med.,2011

2. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial;Bohula;Circulation,2016

3. Obesity and risk of bleeding: the SMART study;Braekkan;J. Thromb. Haemost.,2016

4. Temporal relationship between subclinical atrial fibrillation and embolic events;Brambatti;Circulation,2014

5. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association;Camm;Europace,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of Biosimilars for the Treatment of Cancer;Biosimilars for Cancer Treatment;2024

2. Prevalence, contemporary trends and associated factors of potentially inappropriate prescription of edoxaban in real‐world clinical practice: A subanalysis of the SUNSHINE registry;British Journal of Clinical Pharmacology;2023-12-13

3. Prevalence, risk factors, and prediction of inappropriate use of non-vitamin K antagonist oral anticoagulants in elderly Chinese patients with atrial fibrillation: A study protocol;Frontiers in Cardiovascular Medicine;2022-08-24

4. Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update;Frontiers in Cardiovascular Medicine;2021-06-28